Boris Decarolis
Overview
Explore the profile of Boris Decarolis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Zogchel L, Decarolis B, van Wezel E, Zappeij-Kannegieter L, Gelineau N, Schumacher-Kuckelkorn R, et al.
J Exp Clin Cancer Res
. 2024 Dec;
43(1):331.
PMID: 39722049
Background: Liquid biopsies offer less burdensome sensitive disease monitoring. Bone marrow (BM) metastases, common in various cancers including neuroblastoma, is associated with poor outcomes. In pediatric high-risk neuroblastoma most patients...
2.
Karakaya M, Ragab I, Riehmer V, Erger F, Aly N, Ryu S, et al.
Eur J Hum Genet
. 2024 Dec;
33(3):334-343.
PMID: 39627357
Primary intraosseous vascular malformation (VMPI, #606893) is an ultra-rare disorder caused by biallelic pathogenic variants in ELMO2. To date, only six families with pathogenic ELMO2 variants causing a VMPI phenotype...
3.
Chiapponi C, Hartmann M, Decarolis B, Simon T, Bruns C, Faust M, et al.
J Clin Res Pediatr Endocrinol
. 2023 Mar;
15(3):257-263.
PMID: 36987773
Objective: Differentiated thyroid cancer (DTC) in adolescents rare but with a favorable outcome, despite higher rates of cervical lymph node and pulmonary metastasis compared to adults. The aim of this...
4.
Riedmeier M, Thompson L, Molina C, Decarolis B, Hartel C, Schlegel P, et al.
Endocr Relat Cancer
. 2023 Feb;
30(4).
PMID: 36753311
Histopathological differentiation in pediatric adrenocortical carcinoma (pACC) is difficult and clinical prediction and stratification scores are not evaluated yet. Therefore, this review aims to summarize current evidence on the value...
5.
Riedmeier M, Decarolis B, Haubitz I, Reibetanz J, Wiegering A, Hartel C, et al.
Eur J Endocrinol
. 2022 Oct;
187(6):751-763.
PMID: 36193775
Objective: Pediatric adrenocortical carcinoma (pACC) is rare and prognostic stratification remains challenging. We summarized the clinical prognostic factors of pACC and determined the prognostic value of the pediatric scoring system...
6.
Wiegering V, Riedmeier M, Thompson L, Virgone C, Redlich A, Kuhlen M, et al.
Clin Transl Radiat Oncol
. 2022 May;
35:56-63.
PMID: 35601796
Background And Purpose: Pediatric adrenocortical carcinoma (pACC) is a rare disease with poor prognosis. Publications on radiotherapy (RT) are scarce. This review summarizes the current data on RT for pACC...
7.
Schmidt M, Decarolis B, Franzius C, Hero B, Pfluger T, Rogasch J, et al.
Nuklearmedizin
. 2022 Apr;
61(2):96-110.
PMID: 35421899
No abstract available.
8.
Riedmeier M, Decarolis B, Haubitz I, Muller S, Uttinger K, Borner K, et al.
Cancers (Basel)
. 2021 Nov;
13(21).
PMID: 34771430
Adrenocortical tumors are rare in children. This systematic review summarizes the published evidence on pediatric adrenocortical carcinoma (ACC) to provide a basis for a better understanding of the disease, investigate...
9.
van Wezel E, van Zogchel L, van Wijk J, Timmerman I, Vo N, Zappeij-Kannegieter L, et al.
JCO Precis Oncol
. 2021 May;
3.
PMID: 34036221
Patients And Methods: Microarray data were used to identify genes differentially expressed between ADRN and MES cell lines. Candidate genes were then studied using real-time quantitative polymerase chain reaction in...
10.
Meeser A, Beck B, Dubbers M, Habbig S, Kobe C, Koerber F, et al.
Am J Kidney Dis
. 2021 Feb;
77(3):A11-A13.
PMID: 33618821
No abstract available.